Production of a Human TGF-beta Family Protein with ...

23
IBE Presentation 30 March 2007 Production of a Human TGF-beta Family Protein with Potential as an anti-Cancer Therapeutic Protein From Plant Chloroplast Karen K Oishi, PhD CSO, Sr. VP, Technology Development David N Ducan, PhD President and CEO

Transcript of Production of a Human TGF-beta Family Protein with ...

Page 1: Production of a Human TGF-beta Family Protein with ...

IBE Presentation 30 March 2007

Production of a Human TGF-beta Family Protein with Potential as an

anti-Cancer Therapeutic Protein From Plant Chloroplast

Karen K Oishi, PhDCSO, Sr. VP, Technology Development

David N Ducan, PhDPresident and CEO

Page 2: Production of a Human TGF-beta Family Protein with ...

2IBE Presentation 30 March 2007

Design of the Transformation/Expression Vector to capture themaximum potential of the chloroplast to produce recombinant protein

Basis of hyper-expression system –Chloroplast Transformation Technology(CTT™)

Chloroplast genome

Chloroplast

cDNA gene (transgene)

10-100 chloroplast in each cell, therefore the potential to carry 100 to 10,000 copies of the transgene per plant cell

Plant Cell*

* http://www.progressivegardens.com/knowledge_tree/chloroplast.jpg

Page 3: Production of a Human TGF-beta Family Protein with ...

3IBE Presentation 30 March 2007

Chloroplast Transformation/Expression Vectors

Transformation/Expression Cassette*:The perpendicular dotted line shows the vector sequences that are homologous to native chloroplast DNA, resulting in homologous recombination and site specific integration of the gene cassette into the chloroplast genome.

* Henry Daniell, PhD, University of Central Florida, Orlando, FL

Prr

n

trnAtrnI16

S-3’

Tpsb

A

5’U

TR

Selectable Marker TTransgene

Polycistronic mRNA

Page 4: Production of a Human TGF-beta Family Protein with ...

4IBE Presentation 30 March 2007

Chloroplast Transformation/Expression Vectors

Wakasugi, T, Tsudzuki T, Sugiura M (2001) Photosynthesis Research 70(1):107-118

Site of Insertion Site of Insertion

Page 5: Production of a Human TGF-beta Family Protein with ...

5IBE Presentation 30 March 2007

Generation of Transplastomic Plant LineSingle Transformation Events

2nd Round of Selection

Spectinomycin Selection

Production Seed Line (T0)

• QPCR Analysis gDNA

1st Round of Selection• QPCR Analysis gDNA

Production Seed Line (T1)• QPCR Analysis gDNA

• Elisa – Protein Analysis• SDS-PAGE Western Analysis• Enzyme Assay

0.5 – 1.0Million seeds/plant

Spectinomycin Selection

Gene to Seed 7-8 months Easy scale-up to biomassproduction (48 metric tons/acre) –Kentucky, S Carolina and Missouri

Page 6: Production of a Human TGF-beta Family Protein with ...

IBE Presentation 30 March 2007

Transforming Growth Factors

Mullerian Inhibiting Substance(MIS)

Mammalian Cell Cycle Modulators

Page 7: Production of a Human TGF-beta Family Protein with ...

7IBE Presentation 30 March 2007

TGF-β SuperfamilyThe TGF-β (Transforming Growth Factor) superfamily encompasses a large group of soluble extracellular proteins that are potent regulators of embryonic and adult tissues.

TGF-β superfamily members can direct a wide range of cellular responses including proliferation, cellular morphology, apoptosis, cellular maturation, organogenesis, and tissue homostasis

Members of the family are generally classified as:TGF-β (Transforming Growth Factors)BMP (Bone Morphogenetic Proteins)GDF (Growth and Differentiation factors)Activin

Highly Conserved Structure in Vertebrates and Invertebrates

Page 8: Production of a Human TGF-beta Family Protein with ...

8IBE Presentation 30 March 2007

MIS is a member of the TGF-β family involved with the regression of the Müllerian duct in male fetuses during embryonic development.

Extensive animal studies consistently reveal that MIS is effective against ovarian, uterine, breast, endometrial, and prostate cancers

CHO cells have not been capable of generating adequate supplies for clinical trials or commercial operations due to interference with cellular metabolism in the production cells.

Chlorogen has succeeded in producing bioactive MIS in tobacco and has positioned the company as the singular producer of MIS in plants, and by extension, other TGF-β proteins

Müllerian Inhibiting Substance (MIS)

Page 9: Production of a Human TGF-beta Family Protein with ...

9IBE Presentation 30 March 2007

Human pro-Mullerian Inhibiting Substance from CHO (Chinese Hamster Ovary Cells)

COOH

COOHSS

NH2

NH2

COOH

COOH

NH2

NH2

SS

SS

Cleaved in vitro with procineplasmin

COOH

COOHSS

NH2

NH2

N-glycan

SS

SS

Inactive

Bioactive

Page 10: Production of a Human TGF-beta Family Protein with ...

10IBE Presentation 30 March 2007

aadA3’ 16S trnI 5’ Seq Syn hMIS psbA3’ trnA

PpsbA 5’UTR

Choice of promoters / 5’ UTRs

CP homology CP homologyNco I Xba I

PrrnrbcRBS

rbs 5’ UTR

CTT Transformation Vectors holoMIS

Page 11: Production of a Human TGF-beta Family Protein with ...

11IBE Presentation 30 March 2007

Chicken antibody to cMIS Ag002Antibody detects monomer & cMIS dimer

MIS-Receptor II binding Assay: Elisa-based AssaySoluble MISRII-human Fc fusionAP or HP Conjugated Goat Anti-human FcMIS RII-human Fc fusion binds specifically to bioactive cMIS and not to non-activated holoMIS.

MISRII

Ovarian Cancer Cell

Coat with cMIS

MISRII/FcGoat Anti-human Fc

Detection Tools for hMIS

Page 12: Production of a Human TGF-beta Family Protein with ...

12IBE Presentation 30 March 2007

CTT Derived holo MIS

45 kDa 11.7 kDaCOOH

COOH

NH2

NH2

COOH

COOH

NH2

NH2

Active C-terminal MISHomo-dimer 23.5 kDa

SS

Homo-dimer 90 kDa

SS

SS

COOHNH2

57 kDa

COOHNH2Homo-dimer 114 kDa

SS

SS

SS

Interchain disulfidelinkage

N-terminal aa

C-terminal aa

C-term Fragment

Highly conserved structure and amino acid sequence

pI’s:A) HoloMIS: pH 7.2B) cMIS: pH 8.3

Page 13: Production of a Human TGF-beta Family Protein with ...

IBE Presentation 30 March 2007

Human pro-Mullerian Inhibiting Substance from Tobacco Chloroplast

Reduced/Denatured NuPAGEChicken anti-cMIS HRP

60 kDa

49

35

23

18

12.5

Full lengthmonomer

cMIS

Cont

rol

Non

-tra

nsfo

rmed

Co

ntro

l

CTT-

holo

MIS

cMISmonomer

Page 14: Production of a Human TGF-beta Family Protein with ...

14IBE Presentation 30 March 2007

Small Scale Purification of holoMIS(1) Screw Press ExtractMES Buffer pH5.5

Remove PVPP

(2) Phase SeparateExtract

Differential AmmoniumSulfate Precipitation

(3) 45% AS Precipitation(4) 45% ASP PelletResuspend and dialyze 16 hrsin PBS

(5) S300 Size Chromatography

(6) Anion ExchangeChromatography

(ResourceQ)

Organ Assay TestFor Bioactivity

Page 15: Production of a Human TGF-beta Family Protein with ...

15IBE Presentation 30 March 2007

16 ug tsp

8 ug

4 ug

2 ug

1 ug

0.5 ug

4 ug

2 ug

1 ug tsp

Non-transformed

controlFrac #8 Frac #9 Frac #10 Frac #11

MISRII Receptor Binding Assay of Source Q Protein Fractions

Page 16: Production of a Human TGF-beta Family Protein with ...

16IBE Presentation 30 March 2007

Müllerian Duct Regression Assay

Grade 0 Grade 1 Grade 2

Grade 3 Grade 4 Grade 5

M M

MM M

W

W W

W W W

Data from P Donahoe, MD and D MacLaughlin, PhD, Pediatric Surgery Research Laboratory, Massachusetts General Hospital, Charles River Plaza North, Room 6220, 185 Cambridge Street, Boston, MA 02114

Page 17: Production of a Human TGF-beta Family Protein with ...

17IBE Presentation 30 March 2007

Mullerian Duct Regression Assay

Highly specific and sensitive assay for bioactive MIS

8 ug/mLBioactive (plasmin Cleaved)holoMIS for fullregression

Mullerian Duct (Grade 0)

Mullerian Duct (Grade 1-2)

size reduction

Mullerian Duct (Grade 2-3)

Disruption of internal structure

Mullerian Duct (Grade 3-4)

Duct is breaking apart

Mullerian Duct (Grade 4-5)

No Duct is visible

Page 18: Production of a Human TGF-beta Family Protein with ...

18IBE Presentation 30 March 2007

CTT MIS Resource Q Fraction #8 (100 uL)

WolfianDuct

MullerianDuct

Grade 2+with Slight toxicity

• Fraction #8 was the least active by MISRII:Fc receptor binding assay.• Mullerian duct has size reduction as well as membrane disruption = 2+

Data from P Donahoe, MD and D MacLaughlin, PhD, Pediatric Surgery Research Laboratory, Massachusetts General Hospital, Charles River Plaza North, Room 6220, 185 Cambridge Street, Boston, MA 02114

Page 19: Production of a Human TGF-beta Family Protein with ...

19IBE Presentation 30 March 2007

CTT MIS ResourceQ Fraction #9 (100 uL)

WolfianDuct

MullerianDuct

Grade 5+

• Fraction #9 had the second best MISRII:Fc receptor binding activity.• No visible presence of Mullerian Duct = 5+

Data from P Donahoe, MD and D MacLaughlin, PhD, Pediatric Surgery Research Laboratory, Massachusetts General Hospital, Charles River Plaza North, Room 6220, 185 Cambridge Street, Boston, MA 02114

Page 20: Production of a Human TGF-beta Family Protein with ...

20IBE Presentation 30 March 2007

Process for Bioactivity Testing of CTT-MIS

WolfianDuct

MullerianDuct

Grade 5+

Mullerian Duct RegressionAssay

2

Apoptosis ofHuman OvarianCancer Cell Lines

4

Nude Mice (Immuno compromised)Xenographsof ovarian cancer cells

Mouse A

3AllographsMice – ovarian cancer mouse model

5

Prepre-animal Studies:• Generation of dose response curve • Safety (side effects)

Page 21: Production of a Human TGF-beta Family Protein with ...

21IBE Presentation 30 March 2007

Significant Results

Non-glycosylated TGF-β (MIS) can be assembled properly using CTT

Non-glycosylated TGF-β (MIS) can be processed in plants into a bioactive form of MIS in vivo

CTT has the potential to produce large-quantities of MIS for the ovarian, breast and other potential markets

Exclusive Rights from Tobacco Ventur, LLC:

Karen Keiko Oishi, Leonard Comaratta (2002) “ Gene Expression and Production of TGF-beta Proteins Including Bioactive Mullerian Inhibiting Substance from Plants” US 60/295,545 (National and International Filing)

Chlorogen IP: Karen Keiko Oishi, David Williams (2005) “Expressing TGF-beta Proteins in Plant Plastids”.

Page 22: Production of a Human TGF-beta Family Protein with ...

22IBE Presentation 30 March 2007

Acknowledgements Chlorogen, Inc (Creve Coeur, MO)Karen K Oishi, PhDDavid Corbin, PhDDeb Weissenborn, PhDJoshua HufferLauren GuntherTammy KershnerKathy SchabergSharon BerberichNick DuncanDavid WilliamsBarry Tulk, PhDMelinda Mulesky, PhDSteve HosackBob HeerenSteve HillDave Berry

Mass General Hospital/Harvard (Boston, MO)P Donahoe, MDD MacLaughlin, PhDHerb Lin, PhD

U Missouri, Delta Center (Portageville, MO)Gene Stevens, PhDMatt Rhine

Kentucky Tobacco DevelopmentResearch Center (Lexington, KY)Maelor Davis, PhDOrlando Chambers

MGH Collaboration Funded by NIH SBIR Chlorogen Grant #7 R43 CA093058

Danforth Plant Science Center(Creve Coeur, MO)Roger Beachy, PhDKarel Schubert, PhDEd FisherDean Rochester

Kentucky BioProcessing,LLC(Owensboro, KY)Barry BratcherErnie Hiatt, PhDSteve HumeJim Phelps

Page 23: Production of a Human TGF-beta Family Protein with ...

23IBE Presentation 30 March 2007

Imagine

A Cure for Cancer from Tobacco!